Machine-Learning and Stochastic Tumor Growth Models for Predicting Outcomes in Patients With Advanced Non-Small-Cell Lung Cancer.

Journal: JCO clinical cancer informatics
Published Date:

Abstract

PURPOSE: The prediction of clinical outcomes for patients with cancer is central to precision medicine and the design of clinical trials. We developed and validated machine-learning models for three important clinical end points in patients with advanced non-small-cell lung cancer (NSCLC)-objective response (OR), progression-free survival (PFS), and overall survival (OS)-using routinely collected patient and disease variables.

Authors

  • Kien Wei Siah
    Massachusetts Institute of Technology, Cambridge, MA.
  • Sean Khozin
    US Food and Drug Administration, Silver Spring, MD.
  • Chi Heem Wong
    Massachusetts Institute of Technology, Cambridge, MA.
  • Andrew W Lo
    Massachusetts Institute of Technology, Cambridge, MA.